Article Information
PubMed
History
- Published online May 14, 2012.
Article Versions
- Latest version (April 2, 2012 - 08:20).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 Canadian Medical Association or its licensors
Author Information
- Mahyar Etminan, PharmD MSc⇑,
- Farzin Forooghian, MD MSc,
- David Maberley, MD MSc
- From the Therapeutic Evaluation Unit (Etminan), Pharmaceutical Outcomes Programme, the Child and Family Research Institute, Vancouver, BC; and the Departments of Medicine (Etminan) and Ophthalmology & Visual Sciences (Forooghian, Maberly), University of British Columbia, Vancouver, BC
- Correspondence to:
Mahyar Etminan, metminan{at}popi.ubc.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Jump to section
Related Articles
Cited By...
- The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjogren Syndrome: A General Population-based Study
- Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada
- Pro-inflammatory and anti-angiogenic effects of bisphosphonates on human cultured retinal pigment epithelial cells
- New Bisphosphonate Use Associated with Uveitis and Scleritis
More in this TOC Section
Similar Articles
Collections
